6 noteworthy drugs the FDA approved in 2016

Here are six noteworthy drugs the Food and Drug Administration approved in 2016.

1. In April, the FDA approved Nuplazid as the first drug approved to treat hallucinations and delusions in people with Parkinson's disease.

2. The agency approved Ocaliva in May to treat a rare chronic liver disease known as primary biliary cirrhosis.

3. Epclusa is the first drug approved by the FDA for all six forms of hepatitis C. The treatment was approved in June.

4. The FDA approved Exondys 51 in September. It is the first treatment for Duchenne's muscular dystrophy, a rare degenerative condition that causes muscle weakness, loss of movement and eventually death.

5. Spinraza is the first available treatment for patients with spinal muscular atrophy. The drug was approved in December.

6. The FDA approved Rubraca in December as a new treatment for women with advanced ovarian cancer.

More articles on supply chain:

Trump slams drugmakers at press conference: 'They're getting away with murder'
St. Jude Medical releases cybersecurity updates for vulnerable heart devices
Egalet earns FDA approval for abuse-deterrent opioid painkiller

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months